Cancer Letters
Volume 236, Issue 2 , Pages 292-301, 18 May 2006

Matrilysin over-expression in MCF-7 cells enhances cellular invasiveness and pro-gelatinase activation

Department of Obstetrics and Gynecology, New York University School of Medicine, 550 First Avenue, NB-9N28, New York, NY 10016, USA

Received 6 March 2005; received in revised form 16 May 2005; accepted 18 May 2005.

Abstract 

Matrilysin (MMP-7) is over-expressed in various cancers and is thought to play important roles in tumor invasion and metastasis. However, the function of MMP-7 in breast cancer remains unclear. We therefore examined the expression of the MMP-7 gene in breast cancer (MCF-7) cells and the effect of its over-expression on cellular invasion. We transfected human MMP-7 into MCF-7 cells and selected clones that stably over-expressed the MMP-7 gene. The in vitro invasiveness of MCF-7 cells was quantified by use of the Matrigel invasion assay. Expression of MMP-7 mRNA was analyzed by quantitative RT-PCR. MMP secretion and activation were detected by gelatin zymography. We found that MMP-7-expressing clones had significantly increased invasion (P<0.001), with increased MMP-7 expression and gelatinase activation as compared to the vector controls. We conclude that MMP-7 over-expression correlates with breast cancer in vitro invasiveness and that MMP-7 may promote invasion by increasing the secretion and activation of proMMP-2 and proMMP-9.

Keywords: Matrilysin (matrix metalloproteinase 7, MMP-7), Gelatinase A (MMP-2), Gelatinase B (MMP-9), Breast cancer, Invasion, MCF-7

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0304-3835(05)00496-9

doi:10.1016/j.canlet.2005.05.042

Cancer Letters
Volume 236, Issue 2 , Pages 292-301, 18 May 2006